Daniela Poodts
Overview
Explore the profile of Daniela Poodts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pibuel M, Poodts D, Sias S, Byrne A, Hajos S, Franco P, et al.
Sci Rep
. 2023 Jun;
13(1):9356.
PMID: 37291120
Glioblastoma (GBM) is the most frequent malignant primary tumor of the CNS in adults, with a median survival of 14.6 months after diagnosis. The effectiveness of GBM therapies remains poor,...
2.
Ledesma M, Poodts D, Amoia S, Hajos S, Fundia A, Vay C, et al.
Sci Rep
. 2023 Apr;
13(1):5596.
PMID: 37019937
Chemotherapy mistreatment is partially due to a lack of rapid and reliable tools to discriminate between sensitive and resistant phenotypes. In many cases, the resistance mechanism is not fully understood,...
3.
Pibuel M, Poodts D, Molinari Y, Diaz M, Amoia S, Byrne A, et al.
Br J Cancer
. 2022 Oct;
128(1):12-20.
PMID: 36207608
Although the literature about the functions of hyaluronan and the CD44 receptor in the brain and brain tumours is extensive, the role of the receptor for hyaluronan-mediated motility (RHAMM) in...
4.
Lompardia S, Pibuel M, Diaz M, Poodts D, Hajos S
Glycobiology
. 2022 May;
32(9):743-750.
PMID: 35511737
Cancer is one of the leading causes of death worldwide and has been associated with ageing. Although there are numerous reports that have demonstrated the dual role of hyaluronic acid...
5.
Diaz M, Pibuel M, Paglilla N, Poodts D, Alvarez E, Papademetrio D, et al.
Life Sci
. 2021 Oct;
287:120065.
PMID: 34678263
Aims: Despite continuous improvement in the treatment of acute leukemia, new therapies are still needed to overcome resistance and reduce adverse effects. The aim of this work was to study...
6.
Pibuel M, Poodts D, Diaz M, Molinari Y, Franco P, Hajos S, et al.
Cell Death Discov
. 2021 Oct;
7(1):280.
PMID: 34628469
The extracellular matrix plays a key role in cancer progression. Hyaluronan, the main glycosaminoglycan of the extracellular matrix, has been related to several tumor processes. Hyaluronan acts through the interaction...
7.
Pibuel M, Poodts D, Diaz M, Hajos S, Lompardia S
J Biol Chem
. 2021 Mar;
296:100549.
PMID: 33744285
Advances in cancer biology are revealing the importance of the cancer cell microenvironment on tumorigenesis and cancer progression. Hyaluronan (HA), the main glycosaminoglycan in the extracellular matrix, has been associated...
8.
Lompardia S, Diaz M, Pibuel M, Papademetrio D, Poodts D, Mihalez C, et al.
Sci Rep
. 2020 Jul;
10(1):12079.
PMID: 32669595
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
9.
Pibuel M, Diaz M, Molinari Y, Poodts D, Silvestroff L, Lompardia S, et al.
Glycobiology
. 2020 May;
31(1):29-43.
PMID: 32472122
Glioblastoma (GBM), the most frequent primary tumor of the central nervous system, has a median survival of 14.6 months. 4-Methylumbelliferone (4MU) is a coumarin derivative widely used as a hyaluronan...
10.
Lompardia S, Diaz M, Pibuel M, Papademetrio D, Poodts D, Mihalez C, et al.
Sci Rep
. 2019 Jul;
9(1):10930.
PMID: 31358779
Hyaluronan (HA) is the main glycosaminoglycan of the extracellular matrix. CD44 is the most important HA receptor, and both have been associated with poor prognosis in cancer. Chronic myeloid leukemia...